QT
PLRX icon

Quantamental Technologies’s Pliant Therapeutics PLRX Stock Holding History

Quantamental Technologies’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,018
Closed -$194K – 575
2022
Q4 		$194K Sell
10,018
-6,325
-39% -$132K 0.09% 376
2022
Q3 		$341K Buy
+16,343
New +$313K 0.13% 276

Other funds holding PLRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Quantamental Technologies's PLRX Position: Q1 2023 in Review

Quantamental Technologies sold out of Pliant Therapeutics (PLRX) in Q1 2023, closing a stake of 10,018 shares — an estimated $194K sold.

Quantamental Technologies first reported a position in PLRX in Q3 2022 and held it in 2 quarters. The position peaked at $341K in Q3 2022. 143 funds tracked by Wall St. Rank hold PLRX as of Q1 2023.

  • Quantamental Technologies reported no remaining Pliant Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Quantamental Technologies sold 10,018 Pliant Therapeutics shares in Q1 2023, an estimated $194K.
  • Quantamental Technologies first reported a position in Pliant Therapeutics in Q3 2022 and held it in 2 quarters.
  • Quantamental Technologies's Pliant Therapeutics position peaked at $341K in Q3 2022.
  • 143 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2023.

Based on Quantamental Technologies's 13F filing for Q1 2023, filed 15 May 2023.